Red Queen Bio

Information Security · Cybersecurity

Overview

Red Queen Bio is an AI biosecurity company. Think of us as the cybersecurity layer for biology. AI is making it dramatically easier to design powerful new drugs and therapies, which is extraordinary news for medicine.

Funding and backers

Team
11-50
employees, estimated range
Backers
2
Compound, LongeVC
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
Tractionpublic signals, read monthly
Hacker News stories
1
best: 1 points
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
MetaCTFVenture round $1M · 8 mo ago · Founded 2021 · 1-10 employees
MetaCTF helps companies protect their employee and customer data by making it easier to hire, retain, and upskill their workforce.
C7 Security provides innovative products and services for cybersecurity.
RiotsecurityVenture round $27.6M · 2 yr ago · Founded 2019 · 51-200 employees · 19 roles
We want to encourage employees to adopt better cybersecurity practices in a way that's actually effective, and entertaining enough that the…
Uncloak -Venture round $400k · 7 yr ago · Founded 2017
Cybersecurity Your Business Deserves. Effortless Cybersecurity for Businesses, Ensuring Peace of Mind.
Expert cybersecurity and development services for businesses.
OpenCyber AI, the gamified AI-driven cybersecurity platform teaching the next generation of cybersecurity professionals.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
LongeVCVia a fund
23 portfolio companies: SiPhox Health, Haut.AI, ANI.AI and 20 more
CompoundVia a fund
62 portfolio companies: PayJoy, Panthalassa, Runway and 59 more

News

News DiarioBitcoin 2 months ago
Red Queen Bio recauda USD $36 millones para diseñar anticuerpos con IA
La startup respaldada por OpenAI reunió USD $36 millones para desarrollar anticuerpos con inteligencia artificial. Comenzará con virus de influenza y prevé sus primeros ensayos clínicos en 2027, mientras afirma que no crea ni aísla patógenos peligrosos.
Read more
Report
News TNW Artificial-intelligence 2 months ago
OpenAI-backed Red Queen Bio designs antibodies with AI
OpenAI-backed Red Queen Bio uses AI to design antibodies against bird flu and future viruses, the WSJ reports. It has raised $36M in total.
Read more
Report
News MF Milano Finanza 2 months ago
Red Queen Bio, la startup che usa l"AI per contrastare una futura pandemia causata dall"intelligenza artificiale MilanoFinanza News
La startup di Hannu Rajaniemi e Nikolai Eroshenko utilizza l'intelligenza artificiale per progettare farmaci a base di anticorpi contro nuovi patogeni, prima che futuri sistemi di AI li creino
Read more
Report
News finance.eastmoney.com 2 months ago
OpenAI支持的初创公司Red Queen Bio将于明年开始进行抗体药物人体试验 _ 东方财富网
据报道OpenAI支持的初创公司RedQueenBio将于明年开始进行抗体药物人体试验
Read more
Report